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Identification of Ketoconazole as an AhR-Nrf2
Activator in Cultured Human Keratinocytes:
The Basis of Its Anti-Inflammatory Effect
Gaku Tsuji1,3, Masakazu Takahara1,3, Hiroshi Uchi1,2, Tetsuo Matsuda1, Takahito Chiba1,2,
Satoshi Takeuchi1, Fumiko Yasukawa1,2, Yoichi Moroi1 and Masutaka Furue1,2
Ketoconazole (KCZ) has been shown to exhibit anti-inflammatory effects in addition to its inhibitory effects
against fungi; however, the underlying molecular mechanism remains poorly understood. Aryl hydrocarbon
receptor (AhR), a receptor that is activated by polycyclic aromatic hydrocarbons (PAHs) and halogenated
aromatic hydrocarbons such as dioxin, is a sensor of the redox system against oxidative stress and regulates
nuclear factor-erythroid 2-related factor-2 (Nrf2), a master switch of the redox machinery. To clarify whether KCZ
modulates AhR-Nrf2 function leading to redox system activation, cultured human keratinocytes were treated
with KCZ. Confocal microscopic analysis revealed that KCZ induced AhR nuclear translocation, resulting in the
upregulation of CYP1A1 mRNA and protein expression. Furthermore, KCZ actively switched on Nrf2 nuclear
translocation and quinone oxidoreductase 1 expression. Tumor necrosis factor-a- and benzo(a)pyrene
(BaP)-induced reactive oxidative species (ROS) and IL-8 production were effectively inhibited by KCZ.
Knockdown of either AhR or Nrf2 abolished the inhibitory capacity of KCZ on ROS and IL-8 production. In
addition, KCZ-induced Nrf2 activation was canceled by AhR knockdown. Moreover, KCZ inhibited BaP-induced
8-hydroxydeoxyguanosine and IL-8 production. In conclusion, the engagement of AhR by KCZ exhibits
the cytoprotective effect mediated by the Nrf2 redox system, which potently downregulates either cytokine-
induced (AhR-independent) or PAH-induced (AhR-dependent) oxidative stress.
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INTRODUCTION
Ketoconazole (KCZ) is an azole antifungal agent. KCZ may be
particularly effective against inflammatory skin diseases,
including psoriasis (Farr et al., 1985), acne (De Pedrini
et al., 1988), and atopic dermatitis (Ba¨ck et al., 1995).
The mechanism by which KCZ inhibits skin inflammation
has largely depended on its suppression of Malassezia spp,
which contributes to the aggravation of seborrheric dermatitis
(Gupta et al., 2004) and atopic dermatitis (Darabi et al.,
2009). However, KCZ also exerts a direct anti-inflammatory
effect (Kanda and Watanabe, 2006; Nakashima et al.,
2007), the mechanism of which has remained largely
unknown.
Several studies of oral KCZ-induced hepatic dysfunction
have revealed that KCZ induces aryl hydrocarbon receptor
(AhR) signaling-mediated genes in human hepatocytes
(Casley et al., 2007; Korashy et al., 2007). AhR is activated
by polycyclic aromatic hydrocarbons (PAHs) and haloge-
nated aromatic hydrocarbons such as dioxin. Specifically,
AhR signaling occurs as follows (Ma and Lu, 2003): (1) the
ligand interacts with AhR in the cytoplasm; (2) the
ligand–AhR complex translocates from the cytoplasm into
the nucleus; (3) the ligand–AhR complex forms a heterodimer
ligand/AhR/AhR nuclear translocator in the nucleus; and (4)
the ligand/AhR/AhR nuclear translocator complex binds to
xenobiotic response elements and activates the transcription
of some members of the cytochrome P450 enzyme family
such as CYP1A1, which metabolizes and activates the ligand.
Previous studies, including our report, have shown that
AhR signaling in normal human epidermal keratino-
cytes (NHEKs) functions as a metabolizing system for PAHs
such as benzo(a)pyrene (BaP; Khan et al., 1992; Tsuji et al.,
2011).
Furthermore, AhR signaling has a cross-talk with other
transcription factors (Ko¨hle and Bock, 2007; Haarmann-
Stemmann et al., 2009). In the present study, we focused on
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nuclear factor-erythroid 2-related factor-2 (Nrf2), which is
a key molecule responsible for turning on the protective
systems for cell damage. Nrf2 is anchored to Kelch-like ECH-
associated protein 1 in the cytoplasm. When the Nrf2–Kelch-
like ECH-associated protein 1 complex is disrupted by
an inducer, Nrf2 translocates from the cytoplasm into
the nucleus to bind antioxidant response elements (AREs).
ARE-mediated induction of antioxidant enzymes, including
NAD(P)H:quinone oxidoreductase 1 (Nqo1), is critical for
protection from cell damage caused by reactive oxygen
species (ROS; Jaiswal, 2004).
Therefore, we hypothesized that KCZ may exert its anti-
inflammatory effects on inflammatory skin diseases by
activating Nrf2 via AhR signaling. To prove this, cultured
NHEKs were treated with KCZ. We demonstrated that
KCZ (1) activates AhR signaling in NHEKs, (2) activates
Nrf2 via AhR signaling, and (3) inhibits tumor necrosis
factor-a (TNF-a)- or BaP-induced ROS and IL-8 production
via AhR-Nrf2.
RESULTS
KCZ, terbinafine hydrochloride, BaP, and resveratrol
do not affect NHEK viability
Cell viability was determined by Trypan blue dye exclusion.
Incubation with KCZ (10 nM–1 mM), terbinafine hydrochloride
(TBF; 1 mM), BaP (1 mM), and resveratrol (RES; 1 mM) for
48 hours showed no effect on the viability or morphological
features of NHEKs (data not shown), as described previously
(Kanda and Watanabe, 2006).
KCZ activates AhR signaling in NHEKs
To determine whether KCZ activates AhR signaling, we
examined AhR nuclear translocation. NHEKs were treated
with DMSO (control), KCZ (1 mM), or TBF (1 mM), a non-azole
antifungal agent, for 6 hours. Confocal laser scanning micro
scopy revealed that AhR was mainly localized in the
cytoplasm under unstimulated condition (DMSO treatment;
Figure 1a). Following KCZ treatment, AhR staining was
observed mainly in the nuclei (Figure 1b), indicating that KCZ
induces AhR nuclear translocation in NHEKs. In contrast, TBF
treatment did not affect AhR distribution (Figure 1c) even after
24 hours (data not shown).
Next, we examined whether KCZ induced CYP1A1
expression by quantitative real-time PCR (qRT-PCR) and
western blotting analysis. NHEKs were treated with KCZ
(1 mM) for 3, 6, 24, and 48 hours for qRT-PCR analysis and for
24 and 48 hours for western blotting analysis. KCZ induced
CYP1A1 mRNA and protein upregulation (Figure 1e and f).
Furthermore, NHEKs were treated with different doses of KCZ
(10 nM, 100 nM, and 1 mM) for 3 hours, because AhR began to
translocate into the nuclei at this point (data not shown). KCZ
induced the upregulation of CYP1A1 mRNA in a dose-
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Figure 1. Ketoconazole (KCZ) activated aryl hydrocarbon receptor signaling
in normal human epidermal keratinocytess. Confocal laser scanning
microscopic analysis. (a) DMSO treatment (control), (b) KCZ (1 mM),
(c) terbinafine hydrochloride (1 mM) treatment for 6 hours, and (d) isotype
negative control. Bar¼ 50mm. Representative data, n¼3 (a–d). (e, g)
Quantitative real-time PCR analysis. Treatment with 1 mM KCZ for 3, 6, 24,
and 48 hours or with 10 nM, 100 nM, and 1mM KCZ for 3 hours. CYP1A1
mRNA levels normalized for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA levels were expressed as fold induction compared with
DMSO group. (f, h) Western blotting analysis. Treatment with 1 mM KCZ for
24 and 48 hours or with 10 nM, 100 nM, and 1 mM KCZ for 24 hours. CYP1A1
protein levels were normalized for GAPDH protein levels using ImageJ.
Means±SD, (n¼ 3) (e–h). *Po0.05 (e–h).
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dependent manner (Figure 1g). Western blotting analysis
confirmed that KCZ induced the upregulation of CYP1A1
protein in NHEKs treated with KCZ (100 nM and 1 mM) for 24
or 48 hours (Figure 1h).
KCZ activates Nrf2 signaling in NHEKs
To elucidate whether KCZ activates Nrf2 in NHEKs, we
examined Nrf2 distribution. NHEKs were treated with DMSO
(control) or KCZ (1 mM) for 12 hours. Under unstimulated
condition (DMSO treatment), Nrf2 was mainly localized in
the cytoplasm (Figure 2a). Following KCZ treatment, Nrf2
staining was observed mainly in the nuclei (Figure 2b),
indicating that KCZ induces Nrf2 nuclear translocation.
Next, we examined whether KCZ induced Nrf2 and Nqo1
upregulation. NHEKs were treated with KCZ for 12 hours for
qRT-PCR analysis and for 24 hours for western blotting
analysis. KCZ induced Nrf2 and Nqo1 mRNA and protein
upregulation in a dose-dependent manner (Figure 2d and e).
Furthermore, ELISA-based Nrf2 transcriptional assay,
which detects whether Nrf2 protein interacted with an
oligonucleotide in ARE, confirmed that KCZ-induced nuclear
Nrf2 bound to ARE (Figure 2f).
Nrf2 activation by KCZ requires AhR signaling in NHEKs
To examine whether KCZ activates Nrf2 via AhR signaling,
AhR was knocked down by small interference (si)RNA
transfection. After transfection with siRNA control (si-control)
or siRNA against AhR (si-AhR) for 48 hours, NHEKs were
treated with KCZ (1 mM) or BaP (1 mM) for 12 hours. KCZ
induced Nrf2 nuclear translocation in si-control-transfected
NHEKs (Figure 3a); however, in si-AhR-transfected NHEKs,
the KCZ-induced Nrf2 nuclear translocation was completely
abolished (Figure 3b). In addition, BaP induced Nrf2
upregulation in si-control-transfected NHEKs, which was
inhibited in si-AhR-transfected NHEKs. However, BaP did not
induce Nrf2 nuclear translocation (Supplementary Figure S1
online). Si-AhR transfection successfully knocked down AhR
expression at the protein level (Figure 3d).
AhR and Nrf2 are responsible for the inhibitory effect of KCZ
on TNF-a-induced ROS–IL-8 production
To evaluate the inhibitory effect of KCZ on inflammation, we
used TNF-a to induce ROS-mediated IL-8 production in
NHEKs (Young et al., 2008). After treatment with DMSO
(control) or KCZ (1 mM) for 48 hours, NHEKs were exposed to
TNF-a (10 ngml1) for 30minutes. ROS production was
evaluated using 20,70-dichlorofluorescein diacetate (DCFH-
DA). DMSO (control; Figure 4a) and KCZ (1 mM) treatment for
6, 24, and 48 hours (Figure 4b) did not induce visible ROS
production (Supplementary Figure S2 online). In contrast,
TNF-a markedly induced ROS production in DMSO-treated
NHEKs (control; Figure 4c), but not when NHEKs were
treated with KCZ (Figure 4d).
Next, we examined whether KCZ exerted this anti-
inflammatory effect by AhR-mediated gene expression,
including AhR, Nrf2, and aryl hydrocarbon receptor repressor
(AhRR) genes. AhRR functions as a negative feedback to AhR
signaling, which inhibits CYP1A1 upregulation (Mimura
et al., 1999). TNF-a did not affect AhRR mRNA expression
and KCZ-induced CYP1A1 upregulation (Supplementary
Figure S3 online). siRNA transfection successfully knocked
down Nrf2 expression at the protein level (Figure 3d) and
AhRR expression at the mRNA level (Figure 4i). KCZ (1 mM)
inhibited TNF-a-induced ROS in si-control (Figure 4e) or
si-AhRR (Figure 4h)-transfected NHEKs, which was canceled
in si-AhR (Figure 4f) or si-Nrf2 (Figure 4g)-transfected NHEKs.
Furthermore, we examined the effect of KCZ on IL-8
production (Figure 4, Supplementary Figure S4 online). After
KCZ (100 nM, 1 mM) treatment for 48 hours, NHEKs were
exposed to TNF-a (50 ngml1) for 3 hours. KCZ inhibited
TNF-a-induced IL-8 production in the culture supernatant in
a dose-dependent manner (Figure 4j). More importantly,
AhR or Nrf2 knockdown, but not AhRR knockdown,
canceled this inhibitory effect on TNF-a-induced IL-8
production (Figure 4k).
KCZ inhibits BaP-induced oxidative stress in NHEKs
We hypothesized that KCZ might inhibit oxidative stress
induced by AhR agonists, including PAHs and dioxins
antagonistically, because KCZ also activates AhR signaling.
After KCZ (100 nM, 1 mM) or DMSO (control) treatment for
48 hours, NHEKs were exposed to BaP (1 mM) for 24 hours.
KCZ and BaP did not affect AhRR mRNA expression
(Supplementary Figure S3 online). BaP induced ROS produc-
tion in NHEKs (Figure 5b), which was inhibited by KCZ
treatment (Figure 5c). Furthermore, Nrf2 (Figure 5e), but not
AhRR (Figure 5f), knockdown canceled the inhibitory effect
of KCZ on BaP-induced ROS production. Next, we examined
whether KCZ inhibited BaP-induced IL-8 upregulation (Figure
5g, Supplementary Figure S4 online). KCZ (100 nM and 1 mM)
inhibited BaP-induced IL-8 production in a dose-dependent
manner (Figure 5g). Furthermore, we examined nuclear
8-hydroxydeoxyguanosine (8-OHdG) production resulting
from DNA damage induced by ROS (Saladi et al., 2003).
KCZ (1 mM) treatment for 48 hours did not induce 8-OHdG
production (data not shown). BaP (1 mM) exposure for
24 hours induced 8-OHdG production in DMSO-treated
NHEKs (control), which was significantly inhibited by KCZ
(100 nM, 1 mM) in a dose-dependent manner (Figure 5h).
DISCUSSION
The present study has provided the first evidence that KCZ
induces Nrf2 activation in cultured human keratinocytes
through AhR-dependent mechanisms. Specifically, we have
demonstrated that KCZ induces Nrf2 nuclear translocation
and promotes Nrf2 binding to ARE, leading to Nqo1
upregulation. Nqo1 is a relevant marker for Nrf2 activation
(Marrot et al., 2008), implying KCZ as an Nrf2 inducer and
activator.
Our studies using siRNA targeted against AhR revealed
that AhR is required to initiate Nrf2 translocation after KCZ
treatment (Figure 3a and b). Recent data have provided lines
of evidence regarding the cross-talk between AhR signaling
and Nrf2, leading to the induction of antioxidant enzymes in
human hepatocytes (Yeager et al., 2009). They have
suggested two possible mechanisms by which AhR signaling
www.jidonline.org 61
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Figure 2. Ketoconazole (KCZ) activated nuclear factor-erythroid-2-related factor-2 (Nrf2) in normal human epidermal keratinocytes. Confocal laser scanning
microscopic analysis. (a) DMSO treatment (control). (b) Treatment with 1mM KCZ for 12hours. (c) Isotype negative control. Bar¼ 50mm. Representative data, n¼ 3 (a–c).
(d) Quantitative real-time PCR analysis. Treatment with 100nM and 1mM KCZ for 12hours. Nrf2 or Nqo1 mRNA levels normalized for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA levels were expressed as fold induction compared with the DMSO group. (e) Western blotting analysis. Treatment with 100nM and
1mM KCZ for 24hours. Protein levels were normalized for GAPDH protein levels using ImageJ. (f) ELISA-based Nrf2 transcriptional analysis. Protein levels of nuclear
Nrf2, which interacted with an oligonucleotide in antioxidant response elements were measured. Data are presented as means±SD, n¼3 (d–f). *Po0.05 (d–f).
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activates Nrf2: (1) ROS production caused by CYP1A1
metabolism of a ligand would facilitate Nrf2 nuclear
translocation and (2) AhR might bind to the Nrf2 gene locus
and increase Nrf2 transcription as suggested by Miao et al.
(2005). Our results possibly support the latter mechanism,
because KCZ treatment did not induce ROS production
(Figure 4b, Supplementary Figure S2 online). Although we
showed that KCZ induced AhR nuclear translocation and
CYP1A1 expression, we did not confirm the binding between
KCZ and AhR in NHEKs. KCZ has been shown to directly bind
to AhR and induce AhR nuclear translocation in human
hepatocytes (Korashy et al., 2007), indicating that KCZ may be
a, to our knowledge, previously unreported AhR ligand. In
addition, Henry and Gasiewicz (2008) have determined
specific amino acids within AhR ligand-binding domains,
showing that non-dioxin chemicals bind to AhR. These pre-
vious reports strongly suggest that KCZ activates AhR signaling
in NHEKs through the direct engagement of KCZ to AhR.
Next, we have demonstrated that KCZ exerts an anti-
inflammatory effect against TNF-a- or BaP-induced oxidative
stress. Similar results that KCZ inhibits ROS released by
primed inflammatory cells (Nakashima et al., 2007) and TNF-
a-induced CCL27, CCL12, and CCL5 production in NHEKs
(Kanda and Watanabe, 2006) have been reported; however,
the underlying molecular mechanism remains unknown. The
present study has identified that AhR and Nrf2, but not AhRR,
are critical in the anti-inflammatory effect of KCZ in NHEKs.
The mRNA expression of AhRR, a negative feedback to AhR
activation (Mimura et al., 1999), was not affected by KCZ,
TNF-a, and BaP (Supplementary Figure S3 online). Indeed,
AhRR mRNA expression in NHEKs was much lower than that
in HeLa cells and normal human dermal fibroblasts (NHDFs;
Supplementary Figure S3 online; Tsuchiya et al., 2003;
Akintobi et al., 2007), suggesting that AhRR does not
modulate AhR activation sufficiently in NHEKs.
Results from AhR activation differ with cell types and AhR
ligands. Whether AhR activation inhibits inflammation,
including IL-8 expression, has remained controversial. In
keratinocytes, AhR ligands affect responses of AhR activation
strongly. 6-Formylindolo[3,2-b]carbazole, a tryptophan deri-
vate, and 2,3,7,8-tetrachlorodibenzodioxin induce inflam-
mation by AhR-mediated cyclooxygenase-2 induction
(Fritsche et al., 2007), whereas curcumin, a potent AhR
activator (Rinaldi et al., 2002), induces cyclooxygenase-2
inhibition (Nandal et al., 2009). Furthermore, AhR translo-
cated into nuclei by 2,3,7,8-tetrachlorodibenzodioxin ex-
posure interacts with the NF-k light-chain enhancer of the
activated B-cell (NF-kB) subunit RelB and binds to a RelB/
AhR-responsive element of IL-8 promoter (Vogel et al., 2007).
On the other hand, RES, which is another AhR ligand, inhibits
NF-kB activation (Adhami et al., 2003), although it induces
AhR nuclear translocation (Casper et al., 1999). Thus, the
type of AhR ligand is an important factor in determining the
response of AhR signaling. Some AhR ligands including RES
(Liu et al., 2011) and curcumin (Natarajan et al., 2010)
induce Nrf2 upregulation in human keratinocytes. Activation
of Nrf2-antioxidant signaling attenuates NF-kB- or cycloox-
ygenase-2-induced inflammatory response (Li et al., 2008;
Hwang et al., 2011). Therefore, we believe that the Nrf2
activation by AhR ligands contributes to the subsequent
response of AhR signaling.
The property of KCZ to inhibit TNF-a-induced ROS and
IL-8 production suggests that KCZ can be a therapeutic agent
for various inflammatory skin diseases because ROS trigger
the induction and maintenance of skin inflammation (Bickers
and Athar, 2006) and IL-8 is a major proinflammatory
Anti-AhR Anti-Nrf2
Anti-GAPDHAnti-GAPDH
Si-control Si-AhR Si-control Si-Nrf2
Figure 3. Ketoconazole (KCZ) activated nuclear factor-erythroid-2-related factor-2 (Nrf2) via aryl hydrocarbon receptor (AhR) signaling in normal human
epidermal keratinocytes (NHEKs). After transfection with small interference (si) RNA control (si-control) or siRNA against AhR (si-AhR) for 48 hours, NHEKs
were treated with 1 mM KCZ for 12 hours. Nrf2 distribution was observed by confocal laser scanning microscopy. (a) Si-control-transfected NHEKs. KCZ induced
Nrf2 nuclear translocation as described in Figure 2b. (b) Si-AhR-transfected NHEKs. KCZ-induced Nrf2 nuclear translocation was completely abolished.
(c) Isotype negative control. Bar¼50 mm. (d) Western blotting analysis. Si-AhR or si-Nrf2 transfection successfully knocked down AhR or Nrf2 expression
at the protein level, respectively. Representative data, n¼ 3 (a–d). GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RES, resveratrol.
www.jidonline.org 63
G Tsuji et al.
KCZ Activates Nrf2 via AhR Signaling in NHEKs
cytokine/chemokine activating the recruitment and function
of neutrophils (Baggiolini and Clark-Lewis, 1992). Further-
more, considering that AhR signaling is originally a metabo-
lizing system for PAHs, we evaluated the property of KCZ to
inhibit oxidative stress caused by an AhR agonist, including
PAHs. KCZ inhibited BaP-induced ROS, IL-8, and 8-OHdG
production (Figure 5c, d, g and h). 8-OHdG is a marker of
DNA damage caused by ROS contributing to carcinogenesis
(Saladi et al., 2003). Elucidation of the precise molecular
mechanism by which KCZ inhibits BaP-induced oxidative
stress appears quite difficult in this system, because BaP also
activates AhR signaling in NHEKs. However, Nrf2 knock-
down restored the inhibitory effect of KCZ on BaP-induced
ROS production, suggesting that Nrf2 possibly has an
important role. These data suggest that KCZ may protect
cells from AhR-mediated oxidative stress, including PAHs
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and dioxin toxicity. As AhR-mediated oxidative stress is partly
involved in clinical symptoms of dioxin-overexposed
patients, including Yucheng (Wang et al., 2008) and Yusho
patients (Imamura et al., 2007), KCZ treatment may have a
possibility to improve these symptoms.
We found that 100 nM KCZ was sufficient to inhibit ROS
and IL-8 production. The concentration of 100 nM is much
lower than the peak serum concentration (7.2mM) obtained
from oral KCZ (200mg) treatment (Chin et al., 1995). As oral
KCZ occasionally causes hepatic dysfunction, topical skin
application is used more frequently, suggesting that the KCZ
dose obtained from topical treatment is desirable for in vitro
assay. However, to the best of our knowledge, there are still
no studies that indicate the optimal KCZ dose based on
topical treatment. Molecules with a molecular weight under
500Da can penetrate normal skin (Bos and Meinardi, 2000).
KCZ, having a molecular weight of 531Da, may thus partially
penetrate normal skin. However, KCZ absorption may be
increased in an inflamed skin because the inflammation
impairs the skin barrier function.
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In conclusion, our findings suggest that engagement
of AhR by KCZ induces the cytoprotective effect mediated
by Nrf2 activation, which potently downregulates either
cytokine-induced (AhR-independent) or PAH-induced
(AhR-dependent) oxidative stress in cultured human kerati-
nocytes.
MATERIALS AND METHODS
Regents and antibodies
KCZ, RES, TBF, BaP, and DMSO were purchased from Sigma
Chemical (St Louis, MO). TNF-a was obtained from Peprotech
(Rocky Hill, NJ). Anti-AhR rabbit polyclonal IgG antibody (H-211),
anti-CYP1A1 mouse monoclonal IgG antibody (B-4), anti-Nrf2
polyclonal rabbit IgG antibody (H-300), anti-AhRR rabbit IgG
antibody (D-14), anti-glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) rabbit IgG antibody (FL-335), normal rabbit IgG, and
normal mouse IgG were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-Nqo1 mouse monoclonal IgG (A180) was
procured from Abcam (Cambridge, UK).
Cell culture
NHEKs, NHDFs, obtained from Clonetics-BioWhittaker (San Diego,
CA), and HeLa cells (CCL-2, ATCC) were grown in culture dishes at
37 1C, 5% CO2. NHEKs were cultured in serum-free keratinocyte
growth medium (Lonza, Walkersville, MD) supplemented with
bovine pituitary extract, recombinant epidermal growth factor,
insulin, hydrocortisone, transferrin, and epinephrine. NHDFs and
HeLa cells were cultured in DMEM supplemented with 10% fetal
calf serum, 2mM non-essential amino-acid solution, 2mM pyruvate,
and 2mM HEPES buffer. Culture medium was replaced every 2 days.
At near confluence (70–90%), cells were disaggregated with 0.25%
trypsin/0.01% ethylenediamine tetraacetic acid and subcultured.
Second-to-fourth-passage NHEKs or NHDFs were uszed in all
experiments.
Treatment of cultured NHEKs
NHEKs (1 105) were seeded in 24-well culture plates, allowed to
attach for 24 hours, and subsequently treated with KCZ, TBF, RES,
BaP, TNF-a, or DMSO. Various concentrations of KCZ (10 nM,
100 nM and 1 mM), TBF (1 mM), RES (1 mM), BaP (1 mM), and TNF-a
(10 or 50 ngml1) were prepared in cell culture medium. Control
cultures received medium containing a comparable DMSO
concentration (up to 0.05%). Fresh medium containing KCZ, TBF,
RES, BaP, TNF-a, or DMSO was added as indicated in the figure
legend.
Immunofluorescence and confocal laser scanning
microscopic analysis
NHEKs cultured on slides were washed in phosphate-buffered saline
(PBS), fixed with acetone for 10minutes, and blocked using 10%
BSA in PBS for 30minutes. Samples were incubated with primary
rabbit anti-AhR (1:50) or rabbit anti-Nrf2 (1:50) in PBS overnight at
4 1C. Slides were washed in PBS before incubation with anti-rabbit
(Alexa Fluor 488 or 546, Molecular Probes, Eugene, OR) secondary
antibody for 1.5 hours at room temperature. Slides were mounted
with ProLong Gold antifade reagent (Invitrogen, Carlsbad, CA). All
samples were analyzed using D-Eclipse confocal laser scanning
microscope (Nikon, Tokyo, Japan).
Reverse transcription-PCR and qRT-PCR analyses
Total RNA was extracted using RNeasy Mini kit (Qiagen, Valencia,
CA). Reverse transcription was performed using PrimeScript RT-PCR
kit (Takara Bio, Shiga, Japan). Amplification was started at 95 1C for
10 seconds as the first step, followed by 35 cycles of PCR at 95 1C for
5 seconds, and at 60 1C for 20 seconds. PCR products were analyzed
using electrophoresis, and densitometric analysis was performed
using ImageJ software (NIH). ImageJ is a public domain, Java-based
image processing program developed at the National Institutes of
Health (NIH; Bethesda, MD). qRT-PCR was performed on the
Mx3000p real-time system (Stratagene, La Jolla, CA) using SYBR
Premix Ex Taq (Takara Bio). The amplification protocol was the same
as that with reverse transcription-PCR. mRNA expressions were
measured in triplicate and were normalized for GAPDH expression
levels. The primers from Takara Bio and SABiosciences (Frederick,
MD) were as follows: AhR: forward 50-ATCACCTACGCCAGTCGCA
AG-30 and reverse: 50-AGGCTAGCCAAACGGTCCAAC-30; Nrf2:
forward 50-CTTGGCCTCAGTGATTCTGAAGTG-30 and reverse: 50-C
CTGAGATGGTGACAAGGGTTGTA-30; Nqo1: forward 50-GGATTG
GACCGAGCTGGAA-30 and reverse: 50-AATTGCAGTGAAGATGAA
GGCAAC-30; AhRR: forward 50-GCCTCTGGGCATTTATGGATTTA
AG-30 and reverse: 50-CTGGGCACTCGGTTAGAATAGGAA-30; IL-8:
forward 50-ACTTTCAGAGACAGCAGAGCACACA-30 and reverse:
50-CCTTCACACAGAGCTGCAGAAATC-30; and GAPDH: forward
50-GCACCGTCAAGGCTGAGAAC-30 and reverse: 50-TGGTGAAGA
CGCCAGTGGA-30.
The CYP1A1 primers were PPH01271E (SABiosciences).
Western blotting analysis
NHEKs were incubated with lysis buffer (Complete Lysis-M, Roche
Applied Science, Indianapolis, IN). Lysate protein concentration was
measured using BCA Protein Assay kit (Pierce, Rockford, IL).
Equal amounts of protein (40mg) were dissolved in NuPage LDS
Sample Buffer (Invitrogen) and 10% NuPage Sample Reducing Agent
(Invitrogen). Lysates were boiled at 70 1C for 10minutes and loaded
and run on 4–12% NuPage Bis-Tris Gels (Invitrogen) at 200V for
40minutes. The proteins were transferred onto polyvinylidene
fluoride membranes (Invitrogen) and blocked in 2% BSA in 0.1%
Tween-20 (Sigma-Aldrich) and Tris-buffered saline. Membranes
were probed with anti-AhR, anti-CYP1A1, anti-Nrf2, anti-AhRR, or
anti-Nqo1 antibodies overnight at 4 1C. The secondary antibody
used was anti-rabbit or anti-mouse horseradish peroxidase-conju-
gated IgG antibody. Protein bands were detected using the Western
Breeze kit (Invitrogen). Densitometric analysis of protein band was
performed using ImageJ software (NIH).
Detection of ROS production
DCFH-DA (Molecular Probes) is a cell-permeable non-fluorescent
probe that is de-esterified intracellularly and oxidized to highly
fluorescent 20,70-dichlorofluorescein in the presence of ROS. NHEKs
were incubated with DCFH-DA (5mM) for 30minutes at 37 1C, and
the fluorescence signal of 20,70-dichlorofluorescein (Ex¼ 490 nm),
the oxidation product of DCFH-DA, was analyzed using a D-Eclipse
confocal laser scanning microscope (Nikon).
ELISA
An IL-8 ELISA kit (Invitrogen) and a highly sensitive 8-OHdG
ELISA kit (Japan Institute for the Control of Aging, Shizuoka, Japan)
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were used according to the manufacturer’s protocol. Nuclear
proteins from NHEKs were extracted using NE-PER Nuclear and
Cytoplasmic Extraction Reagents (Thermo Scientific, Rockford, IL).
Optical density was measured using Labsystems Multiskan MS
Analyzer (Thermo Bionalysis Japan, Tokyo, Japan).
ELISA-based Nrf2 transcriptional assay
Protein levels of Nrf2 interacted with an oligonucleotide contained
in ARE were measured by TransAM Nrf2 (Active Motif, Carlsbad,
CA). After KCZ treatment for 12 hours, nuclear extracts (10mg) from
NHEKs were used as samples. Optical density was measured using
Labsystems Multiskan MS Analyzer (Thermo Bionalysis Japan).
Transfection with AhR, Nrf2, or AhRR-targeted specific
small interference RNA
SiRNA targeted against AhR (si-AhR, s1200), Nrf2 (si-Nrf2, s9492)
and AhRR (si-AhRR, s22144) and siRNA consisting of a scrambled
sequence that would not lead to specific degradation of any cellular
message (si-control) were purchased from Ambion (Austin, TX).
NHEKs cultured in 24-well plates were incubated with mix from
HiPerFect Transfection kit (Qiagen, Courtaboeuf, France) containing
10 nM siRNA and 3.0 ml of HiPerFect reagent in 0.5ml of culture
medium. After a 48-hour incubation period, siRNA-transfected
NHEKs were treated with KCZ for 48 hours. siRNA transfection
showed no effect on cell viability, as demonstrated by microscopic
examination (data not shown).
Statistical analysis
Unpaired Student’s t-test was used to analyze results, and a P-value
o0.05 was considered to indicate a statistically significant difference.
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